Company Filing History:

7 out of 1,451

Sanofi

Years Active: 1994-2007

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7288659 - Acylaminothiazole derivatives, their preparation and therapeutic use (2007-10-30),

2. 5798353 - Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one (1998-08-25),

3. 5731340 - Glycinamide derivatives, processes for their preparation and medicines (1998-03-24),

4. 5719143 - Polysubstituted 3-acylamino-5-phenyl-1, 4-benzodiazepin-2-one (1998-02-17),

5. 5607952 - Substituted 4-phenylthiazole derivatives, process for their preparation (1997-03-04),

6. 5578633 - N-sulfonylindoline derivatives, their preparation and the pharmaceutical (1996-11-26),

7. 5481005 - N-sulfonylindoline derivatives, their preparation and the pharmaceutical (1996-01-02),

8. 5397801 - N-sulfonylindoline derivatives, their preparation and the pharmaceutical (1995-03-14),

9. 5338755 - N-sulfonylindoline derivatives, their preparation and the pharmaceutical (1994-08-16),

Title: The Innovations of Paul De Cointet

Introduction

Paul De Cointet is a notable inventor based in Toulouse, France, known for his substantial contributions to the field of pharmaceuticals. With a remarkable portfolio of 9 patents, his work focuses on innovative compounds with therapeutic applications.

Latest Patents

De Cointet's latest patents include "Acylaminothiazole derivatives, their preparation and therapeutic use," which describes a compound characterized by a complex general formula. This invention has the potential for significant therapeutic use due to its variety of substituents, allowing for diverse applications in treatments. Another noteworthy patent is for "Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one," which deals with compounds having a specific formula that showcases his innovative approach to medicinal chemistry.

Career Highlights

Throughout his career, Paul De Cointet has worked with esteemed companies such as Sanofi and Elf Sanofi. His experience in these organizations has greatly enriched his understanding of the pharmaceutical industry and has enabled him to drive remarkable innovations in drug development.

Collaborations

De Cointet has collaborated with accomplished professionals like Jean-Pierre Maffrand and Jean Wagnon. These partnerships have not only facilitated the sharing of knowledge but also enhanced his ability to innovate within the pharmaceutical sector.

Conclusion

Paul De Cointet's contributions to the field of innovation through his patents highlight his role as a key figure in medicinal chemistry. His extensive body of work continues to influence the development of new therapies, showcasing the importance of inventors in advancing science and technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.